Bienvenue sur HématoStat.net. Nous sommes le : 22, November 2024
Réf :HematoStat.net ; 1 (12) : V33
Courtney D DiNardo and al. Enasidenib plus azacitidine versus azacitidine alone in patients with newly diagnosed, mutant-IDH2 acute myeloid leukaemia (AG221-AML-005): a single-arm, phase 1b and randomised, phase 2 tril.. The Lancet Oncology. Vol22, Issue11, p1597-1608. Doi : 10.1016/S1470-2045(21)00494-0
View all posts
Save my name, email, and website in this browser for the next time I comment.
Δ